Fennec Pharmaceuticals (FRX) Competitors

C$8.87 0.00 (0.00%)

As of 05/4/2026 05:00 PM Eastern

FRX vs. TLRY, ITH, TEV, NOT, and PYR

Should you be buying Fennec Pharmaceuticals stock or one of its competitors? The main competitors of Fennec Pharmaceuticals include Tilray Brands (TLRY), International Tower Hill Mines (ITH), Tervita (TEV), Noront Resources (NOT), and PyroGenesis Canada Inc. (PYR.V) (PYR). These companies are all part of the "pharmaceutical products" industry.

How does Fennec Pharmaceuticals compare to Tilray Brands?

Tilray Brands (TSE:TLRY) and Fennec Pharmaceuticals (TSE:FRX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

: In the previous week, Tilray Brands had 2 more articles in the media than Fennec Pharmaceuticals. MarketBeat recorded 2 mentions for Tilray Brands and 0 mentions for Fennec Pharmaceuticals. Tilray Brands' average media sentiment score of 0.36 beat Fennec Pharmaceuticals' score of 0.00 indicating that Tilray Brands is being referred to more favorably in the media.
Company Overall Sentiment
Tilray Brands Neutral
Fennec Pharmaceuticals Neutral
: 4.1% of Tilray Brands shares are owned by institutional investors. Comparatively, 12.3% of Fennec Pharmaceuticals shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by insiders. Comparatively, 16.2% of Fennec Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
: Fennec Pharmaceuticals has lower revenue, but higher earnings than Tilray Brands. Fennec Pharmaceuticals is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Tilray Brands C$858.28M 1.09 -C$183.24M -C$14.63 N/A
Fennec Pharmaceuticals C$44.64M 6.90 -C$800.44K -C$0.34 N/A
: Fennec Pharmaceuticals has a net margin of -22.69% compared to Tilray Brands' net margin of -158.75%. Tilray Brands' return on equity of -88.06% beat Fennec Pharmaceuticals' return on equity.
Company Net Margins Return on Equity Return on Assets
Tilray Brands -158.75% -88.06% -1.41%
Fennec Pharmaceuticals -22.69% -236.42% 8.88%
: Tilray Brands has a beta of 3.243166, indicating that its stock price is 224% more volatile than the S&P 500. Comparatively, Fennec Pharmaceuticals has a beta of 3.218074, indicating that its stock price is 222% more volatile than the S&P 500.
: Tilray Brands currently has a consensus target price of C$13.30, suggesting a potential upside of 70.51%. Given Tilray Brands' higher possible upside, research analysts clearly believe Tilray Brands is more favorable than Fennec Pharmaceuticals.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
Fennec Pharmaceuticals
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

1 Strong Buy rating(s)
4.00

Company	Overall Sentiment
Tilray Brands	Neutral
Fennec Pharmaceuticals	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	C$858.28M	1.09	-C$183.24M	-C$14.63	N/A
Fennec Pharmaceuticals	C$44.64M	6.90	-C$800.44K	-C$0.34	N/A

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-158.75%	-88.06%	-1.41%
Fennec Pharmaceuticals	-22.69%	-236.42%	8.88%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Fennec Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00

Summary

Fennec Pharmaceuticals beats Tilray Brands on 9 of the 16 factors compared between the two stocks.

How does Fennec Pharmaceuticals compare to International Tower Hill Mines?

Fennec Pharmaceuticals (TSE:FRX) and International Tower Hill Mines (TSE:ITH) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations.

: In the previous week, International Tower Hill Mines had 1 more articles in the media than Fennec Pharmaceuticals. MarketBeat recorded 1 mentions for International Tower Hill Mines and 0 mentions for Fennec Pharmaceuticals. International Tower Hill Mines' average media sentiment score of 1.05 beat Fennec Pharmaceuticals' score of 0.00 indicating that International Tower Hill Mines is being referred to more favorably in the news media.
Company Overall Sentiment
Fennec Pharmaceuticals Neutral
International Tower Hill Mines Positive
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fennec Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

1 Strong Buy rating(s)
4.00
International Tower Hill Mines
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: Fennec Pharmaceuticals has higher revenue and earnings than International Tower Hill Mines. International Tower Hill Mines is trading at a lower price-to-earnings ratio than Fennec Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Fennec Pharmaceuticals C$44.64M 6.90 -C$800.44K -C$0.34 N/A
International Tower Hill Mines N/A N/A -C$2.36M -C$0.02 N/A
: International Tower Hill Mines has a net margin of 0.00% compared to Fennec Pharmaceuticals' net margin of -22.69%. International Tower Hill Mines' return on equity of -8.03% beat Fennec Pharmaceuticals' return on equity.
Company Net Margins Return on Equity Return on Assets
Fennec Pharmaceuticals -22.69% -236.42% 8.88%
International Tower Hill Mines N/A -8.03% -3.65%
: Fennec Pharmaceuticals has a beta of 3.218074, indicating that its share price is 222% more volatile than the S&P 500. Comparatively, International Tower Hill Mines has a beta of 2.043244, indicating that its share price is 104% more volatile than the S&P 500.
: 12.3% of Fennec Pharmaceuticals shares are held by institutional investors. Comparatively, 8.8% of International Tower Hill Mines shares are held by institutional investors. 16.2% of Fennec Pharmaceuticals shares are held by company insiders. Comparatively, 0.5% of International Tower Hill Mines shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Company	Overall Sentiment
Fennec Pharmaceuticals	Neutral
International Tower Hill Mines	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fennec Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00
International Tower Hill Mines	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fennec Pharmaceuticals	C$44.64M	6.90	-C$800.44K	-C$0.34	N/A
International Tower Hill Mines	N/A	N/A	-C$2.36M	-C$0.02	N/A

Company	Net Margins	Return on Equity	Return on Assets
Fennec Pharmaceuticals	-22.69%	-236.42%	8.88%
International Tower Hill Mines	N/A	-8.03%	-3.65%

Summary

Fennec Pharmaceuticals beats International Tower Hill Mines on 9 of the 14 factors compared between the two stocks.

How does Fennec Pharmaceuticals compare to Tervita?

Fennec Pharmaceuticals (TSE:FRX) and Tervita (TSE:TEV) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations.

: In the previous week, Fennec Pharmaceuticals' average media sentiment score of 0.00 equaled Tervita'saverage media sentiment score.
Company Overall Sentiment
Fennec Pharmaceuticals Neutral
Tervita Neutral
: Given Tervita's higher probable upside, analysts clearly believe Tervita is more favorable than Fennec Pharmaceuticals.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fennec Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

1 Strong Buy rating(s)
4.00
Tervita
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: Fennec Pharmaceuticals has higher earnings, but lower revenue than Tervita. Fennec Pharmaceuticals is trading at a lower price-to-earnings ratio than Tervita, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Fennec Pharmaceuticals C$44.64M 6.90 -C$800.44K -C$0.34 N/A
Tervita C$1.36B 0.00 -C$1.04M -C$0.01 N/A
: Tervita has a net margin of 0.00% compared to Fennec Pharmaceuticals' net margin of -22.69%. Tervita's return on equity of 0.00% beat Fennec Pharmaceuticals' return on equity.
Company Net Margins Return on Equity Return on Assets
Fennec Pharmaceuticals -22.69% -236.42% 8.88%
Tervita N/A N/A N/A
: 12.3% of Fennec Pharmaceuticals shares are held by institutional investors. 16.2% of Fennec Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Company	Overall Sentiment
Fennec Pharmaceuticals	Neutral
Tervita	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fennec Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00
Tervita	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fennec Pharmaceuticals	C$44.64M	6.90	-C$800.44K	-C$0.34	N/A
Tervita	C$1.36B	0.00	-C$1.04M	-C$0.01	N/A

Company	Net Margins	Return on Equity	Return on Assets
Fennec Pharmaceuticals	-22.69%	-236.42%	8.88%
Tervita	N/A	N/A	N/A

Summary

Fennec Pharmaceuticals beats Tervita on 7 of the 12 factors compared between the two stocks.

How does Fennec Pharmaceuticals compare to Noront Resources?

Fennec Pharmaceuticals (TSE:FRX) and Noront Resources (CVE:NOT) are both small-cap pharmaceutical products companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.

: In the previous week, Fennec Pharmaceuticals' average media sentiment score of 0.00 equaled Noront Resources'average media sentiment score.
Company Overall Sentiment
Fennec Pharmaceuticals Neutral
Noront Resources Neutral
: Noront Resources has lower revenue, but higher earnings than Fennec Pharmaceuticals. Fennec Pharmaceuticals is trading at a lower price-to-earnings ratio than Noront Resources, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Fennec Pharmaceuticals C$44.64M 6.90 -C$800.44K -C$0.34 N/A
Noront Resources N/A N/A N/A -C$0.15 N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fennec Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

1 Strong Buy rating(s)
4.00
Noront Resources
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: 12.3% of Fennec Pharmaceuticals shares are held by institutional investors. 16.2% of Fennec Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
: Noront Resources has a net margin of 0.00% compared to Fennec Pharmaceuticals' net margin of -22.69%. Noront Resources' return on equity of 0.00% beat Fennec Pharmaceuticals' return on equity.
Company Net Margins Return on Equity Return on Assets
Fennec Pharmaceuticals -22.69% -236.42% 8.88%
Noront Resources N/A N/A N/A

Company	Overall Sentiment
Fennec Pharmaceuticals	Neutral
Noront Resources	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fennec Pharmaceuticals	C$44.64M	6.90	-C$800.44K	-C$0.34	N/A
Noront Resources	N/A	N/A	N/A	-C$0.15	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fennec Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00
Noront Resources	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Net Margins	Return on Equity	Return on Assets
Fennec Pharmaceuticals	-22.69%	-236.42%	8.88%
Noront Resources	N/A	N/A	N/A

Summary

Fennec Pharmaceuticals beats Noront Resources on 6 of the 10 factors compared between the two stocks.

How does Fennec Pharmaceuticals compare to PyroGenesis Canada Inc. (PYR.V)?

PyroGenesis Canada Inc. (PYR.V) (CVE:PYR) and Fennec Pharmaceuticals (TSE:FRX) are both small-cap pharmaceutical products companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership.

: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PyroGenesis Canada Inc. (PYR.V)
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Fennec Pharmaceuticals
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

1 Strong Buy rating(s)
4.00
: PyroGenesis Canada Inc. (PYR.V) has a net margin of 0.00% compared to Fennec Pharmaceuticals' net margin of -22.69%. PyroGenesis Canada Inc. (PYR.V)'s return on equity of 0.00% beat Fennec Pharmaceuticals' return on equity.
Company Net Margins Return on Equity Return on Assets
PyroGenesis Canada Inc. (PYR.V) N/A N/A N/A
Fennec Pharmaceuticals -22.69% -236.42% 8.88%
: 12.3% of Fennec Pharmaceuticals shares are owned by institutional investors. 16.2% of Fennec Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
: In the previous week, PyroGenesis Canada Inc. (PYR.V) had 2 more articles in the media than Fennec Pharmaceuticals. MarketBeat recorded 2 mentions for PyroGenesis Canada Inc. (PYR.V) and 0 mentions for Fennec Pharmaceuticals. PyroGenesis Canada Inc. (PYR.V)'s average media sentiment score of 0.00 equaled Fennec Pharmaceuticals'average media sentiment score.
Company Overall Sentiment
PyroGenesis Canada Inc. (PYR.V) Neutral
Fennec Pharmaceuticals Neutral
: Fennec Pharmaceuticals has higher revenue and earnings than PyroGenesis Canada Inc. (PYR.V). PyroGenesis Canada Inc. (PYR.V) is trading at a lower price-to-earnings ratio than Fennec Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
PyroGenesis Canada Inc. (PYR.V) C$6.01M 100.97 -C$3.94M -C$0.03 N/A
Fennec Pharmaceuticals C$44.64M 6.90 -C$800.44K -C$0.34 N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PyroGenesis Canada Inc. (PYR.V)	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Fennec Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00

Company	Net Margins	Return on Equity	Return on Assets
PyroGenesis Canada Inc. (PYR.V)	N/A	N/A	N/A
Fennec Pharmaceuticals	-22.69%	-236.42%	8.88%

Company	Overall Sentiment
PyroGenesis Canada Inc. (PYR.V)	Neutral
Fennec Pharmaceuticals	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PyroGenesis Canada Inc. (PYR.V)	C$6.01M	100.97	-C$3.94M	-C$0.03	N/A
Fennec Pharmaceuticals	C$44.64M	6.90	-C$800.44K	-C$0.34	N/A

Summary

Fennec Pharmaceuticals beats PyroGenesis Canada Inc. (PYR.V) on 8 of the 13 factors compared between the two stocks.

Get Fennec Pharmaceuticals News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FRX vs. The Competition

Export

Metric	Fennec Pharmaceuticals	Biotechnology Industry	Medical Sector	TSE Exchange
Market Cap	C$307.90M	C$446.06M	C$6.25B	C$11.72B
Dividend Yield	2.02%	3.86%	2.73%	6.22%
P/E Ratio	-26.09	4.19	29.04	23.83
Price / Sales	6.90	6,879.71	476.61	13.46
Price / Cash	11.66	13.13	27.62	82.69
Price / Book	7.89	77.74	9.67	4.48
Net Income	-C$800.44K	-C$96.07M	C$3.55B	C$300.68M
7 Day Performance	-3.59%	0.71%	1.70%	0.12%
1 Month Performance	-0.67%	3.87%	5.62%	2.88%
1 Year Performance	3.74%	48.54%	34.41%	57.78%

Fennec Pharmaceuticals Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FRX Fennec Pharmaceuticals	N/A	C$8.87 flat	N/A	N/A	C$307.90M	C$44.64M	N/A	10
TLRY Tilray Brands	1.5363 of 5 stars	C$9.23 -2.4%	C$13.30 +44.1%	N/A	C$1.10B	C$858.28M	N/A	2,650
ITH International Tower Hill Mines	N/A	C$3.61 +5.6%	N/A	N/A	C$944.51M	N/A	N/A	220
TEV Tervita	N/A	N/A	N/A	N/A	C$672.00M	C$1.36B	N/A	36,800	Gap Up
NOT Noront Resources	N/A	C$1.10 -0.5%	N/A	N/A	C$612.18M	N/A	N/A	101,700	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:FRX) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Fennec Pharmaceuticals (FRX) Competitors

FRX vs. TLRY, ITH, TEV, NOT, and PYR

How does Fennec Pharmaceuticals compare to Tilray Brands?

Summary

How does Fennec Pharmaceuticals compare to International Tower Hill Mines?

Summary

How does Fennec Pharmaceuticals compare to Tervita?

Summary

How does Fennec Pharmaceuticals compare to Noront Resources?

Summary

How does Fennec Pharmaceuticals compare to PyroGenesis Canada Inc. (PYR.V)?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FRX vs. The Competition

Fennec Pharmaceuticals Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Fennec Pharmaceuticals (FRX) Competitors

FRX vs. TLRY, ITH, TEV, NOT, and PYR

How does Fennec Pharmaceuticals compare to Tilray Brands?

Summary

How does Fennec Pharmaceuticals compare to International Tower Hill Mines?

Summary

How does Fennec Pharmaceuticals compare to Tervita?

Summary

How does Fennec Pharmaceuticals compare to Noront Resources?

Summary

How does Fennec Pharmaceuticals compare to PyroGenesis Canada Inc. (PYR.V)?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FRX vs. The Competition

Fennec Pharmaceuticals Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools